Przejdź do zawartości
Merck

OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.

Oncotarget (2015-04-25)
Jae-Hwan Kim, Soon-Min Lee, Jong-Hyuk Lee, Sohyun Chun, Byung-Hee Kang, Sojung Kwak, Jae-Seok Roe, Tae Wan Kim, Hyunsoo Kim, Woo Ho Kim, Eun-Jung Cho, Hong-Duk Youn
ABSTRAKT

2-oxogluatrate and Fe(II)-dependent oxygenase domain-containing protein 1 (OGFOD1) was recently revealed to be a proline hydroxylase of RPS23 for translational termination. However, OGFOD1 is nuclear, whereas translational termination occurs in the cytoplasm, raising the possibility of another function of OGFOD1 in the nucleus. In this study, we demonstrate that OGFOD1 is involved in cell cycle regulation. OGFOD1 knockdown in MDA-MB-231 breast cancer cells significantly impeded cell proliferation and resulted in the accumulation of G1 and G2/M cells by decreasing the mRNA levels of G1/S transition- and G2/M-related transcription factors and their target genes. We also confirmed that OGFOD1 is highly expressed in breast cancer tissues by bioinformatic analysis and immunohistochemistry. Thus, we propose that OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-trimethyl Histone H3 (Lys27) Antibody, from rabbit, purified by affinity chromatography
Sigma-Aldrich
Anti-OGFOD1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-74, purified immunoglobulin, buffered aqueous solution